β-Adrenergic stimulation

Handbook of Experimental Pharmacology

Volumn 195, Issue , 2010, Pages 227-249

  Van Eenoo, Peter ^a   Delbeke, Frans T ^b  

^a GHENT UNIVERSITY   (Belgium)

^b NONE

Author keywords

Beta agonist; Chromotography; Mass spectrometry; Metabolism; Stimulant

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ADRAFINIL; AMPHETAMINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROMANTAN; CENTRAL STIMULANT AGENT; CLENBUTEROL; COCAINE; EPHEDRINE; FENOTEROL; FORMOTEROL; ISOPRENALINE; MEPHENTERMINE; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; NORFENFLURAMINE; NORPSEUDOEPHEDRINE; PEMOLINE; PHENMETRAZINE; PHENTERMINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; SALBUTAMOL; SALMETEROL; STRYCHNINE; TERBUTALINE; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; NORADRENALIN;

ADRENERGIC SYSTEM; BETA ADRENERGIC STIMULATION; DOPING; DRUG MECHANISM; DRUG STRUCTURE; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH; PRIORITY JOURNAL; REVIEW; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METHODOLOGY; NERVOUS SYSTEM FUNCTION; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; HUMANS; MASS SPECTROMETRY; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-2; SYMPATHOMIMETICS;

EID: 77449142422     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-79088-4_11     Document Type: Review

References (72)

1. Armstrong DJ (1988) Sympathomimetic amines and their antagonists. In: Mottram DR (ed) Drugs in sport. E & FN Spon Ltd, London
2. Avois L, Robinson N, Saudan C, Baume N, Mangin P, Saugy M (2008) Central nervous system stimulants and sport practice. Br J Sports Med 40(Suppl I):i16-i20
3. Ayotte C (1993) Old doping agent, old method: pemolin TMS-derivative. In: Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, Rauth S (eds) Recent advances in doping analysis. Sport & Buch Strauss, Cologne, Germany, pp 111-116
4. Ayotte C, Goudreault D (1999) The detection of new synthetic drugs in athlete's urine samples. J Toxicol - Toxin Rev 18:113-123
5. Baak MA (2000) Bèta-agonisten en bètablokkers. In: Hartgens F, Kuipers H (eds) Verboden middelen in de sport. Bohn Stafleu Van Loghum, Houtem, The Netherlands
6. Bell DG, Jacobs I (1999) Combined caffeine and ephedrine ingestion improves run times of Canadian Forces warrior test. Aviat Space Environ Med 70:325-329
7. Bell DG, Jacobs I, Zamecnik J (1998) Effects of caffeine, ephedrine and their combination on time to exhaustion during high intensity exercise. Eur J Appl Physiol 77:427-433
8. Bell DG, Jacobs I, Ellerington K (2001) Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc 33:1399-1403
9. Bruins AP (1998) Mechanistic aspects of electrospray ionization. J Chromatogr A 794: 345-347
10. Clemons JM, Crosby SL (1993) Cardiopulmonary and subjective effects of a 60 mg dose of pseudoephedrine on graded treadmill exercise. J Sports Med Phys Fitness 33:405-412
11. Davis E, Loiacono R, Summers RJ (2008) The rush to adrenaline: drugs in sport acting on the β-adrenergic system. Br J Pharmacol 154:584-597
12. De Boer D (2000) Analyse van het urinemonster. In: Hartgens F, Kuipers H (eds) Verboden middelen in de sport. Bohn Stafleu Van Loghum, Houtem, The Netherlands
13. De Rose EH (2008) Doping in athletes - an update. Clin Sports Med 27:107-130
14. Delbeke FT, Debackere M (1975) Isolation and detection of methylphenidate, phacetoperane and some other sympathomimetic central nervous stimulants with special reference to doping. I. Electron capture GC detection procedure for some secondary amines. J Chromatogr 106: 412-417
15. Deventer K, Van Eenoo P, Delbeke FT (2005) Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography/mass spectrometry with scan-to-scan polarity switching. Rapid Commun Mass Spectrom 19:90-98
16. Deventer K, Van Eenoo P, Delbeke FT (2006) Screening for amphetamine and amphetamine-type drugs in doping analysis by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20:877-885
17. n. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (15). Sport & Buch Strauss, Cologne, Germany, pp 363-366
18. Deventer K, Pozo OJ, Van Eenoo P, Delbeke FT (2008) Detection of doping agents by LC-MS and LC-MS-MS. LCGC N Am 26:376-389
19. Deventer K, Van Thuyne W, Mikulc?íková P, Van Eenoo P, Delbeke FT (2007b) Detection of selected stimulants as contaminants in solid nutritional supplements by liquid chromatography-mass spectrometry. Food Chem 103:1508-1513
20. Deventer K, Pozo OJ, Van Eenoo P, Delbeke FT (2009) Development and validation of an LC-MS/MS method for the quantification of ephedrines in urine. J Chromatogr B 877:369-374
21. Docherty JR (2008) Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). Br J Pharmacol 154:606-622
22. George AJ (1988) Central nervous stimulants. In: Mottram DR (ed) Drugs in sport. E & FN Spon Ltd, London, UK
23. Gilber C (1995) Optimal physical performance in athletes: key roles of dopamine in specific neurotransmitter/hormonal mechanism. Mech Ageing Dev 84:83-102
24. Gillies H, Derman WE, Noakes TD, Smith P, Evans A, Gabriels G (1996) Pseudoephedrine is without ergogenic effects during prolonged exercise. J Appl Physiol 81:2611-2617
25. Hager JW (2004) Recent trends in mass spectrometer development. Anal Bioanal Chem 378:845-850
26. Hatton CK (2007) Beyond sports-doping headlines: the science of laboratory tests for performance-enhancing drugs. Pediatr Clin N Am 54:713-733
27. Hemmersbach P, de la Torre R (1996) Stimulants, narcotics and β-blockers: 25 years of development in analytical techniques for doping control. J Chromatogr B 687:221-238
28. Kaufman KR, Gerner R (2005) Modafinil in sports ethical considerations. Br J Sports Med 39:241-244
29. Kindermann W, Meyer T (2006) Inhaled β2 agonists and performance in competitive athletes. Br J Sports Med 40(Suppl 1):i43-i47
30. Kinney AR, Suan CA, Stenhouse AM (2005) The detection of modafinil and its major metabolite in equine urine by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 19:1217-1220
31. Kraemer T, Maurer HH (1998) Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine. J Chromatogr B 713: 163-187
32. Kudrin VS, Sergeeva SA, Krasnykh LM, Miroshnichenko II, Grekhova TV, Gainetdinov RR (1995) The effect of bromantane on the dopamine and serotinergic systems of the rat brain. Eksp Klin Farmacol 58:8
33. Libeer JC, Schepens P (1978) GLC determination of pemoline in biological fluids. J Pharm Sci 67:419-421
34. Logan BK (2002) Metamphetamine - effects on human performance and behavior. Forensic Sci Rev 14:133-151
35. Lopez FA (2006) ADHD: new pharmacological treatments on the horizon. J Dev Behav Pediatr 27:410-416
36. Martins LF, Yegles M, Chung H, Wennig R (2006) Sensitive, rapid and validated gas chromatography/negative ion chemical ionization-mass spectrometry assay including derivatisation with a novel chiral agent for the enantioselective quantification of amphetamine-type stimulants in hair. J Chromatogr B 842:98-105
37. Morozov IS, Efimova LP, Kryshanovskii SA (2000) The effects of bromantane on the cardiovascular and sympathetic-adrenal systems in animals. Ksp Klin Farmakol 63:33-36
38. Nielen MFW, Van Engelen MC, Zuiderent R, Ramaker R (2007) Screening and confirmation criteria for hormone residue analysis using liquid chromatography accurate mass time-of-flight, Fourier transform ion cyclotron resonance and orbitrap mass spectrometry techniques. Anal Chim Acta 586:122-129
39. Niessen WMA (1999) State-of-the-art liquid chromatography-mass spectrometry. J Chromatogr A 856:179-197
40. Niessen WMA, Tinke AP (1995) Liquid chromatography-mass spectrometry. General principles and instrumentation. J Chromatogr A 703:37-57
41. Parry SJ (2006) Doping in the UK: Alain and Dwain, Rio and Greg-not guilty? Sport Soc 9: 269-296
42. Pereira MG, Padilha MC, Bento RMA, Cunha TP, Lascas NAG, Aquino Neto FR (2008) Analytical and logistical improvements in doping-control analysis at the 2007 Pan-American Games. Trac-Trends Anal Chem 27:648-656
43. Rang HO, Dale MM, Ritter JM (2001) Pharmacology, 4th edn. Churchill Livingstone, Edingburgh
44. Sizoi VF, Bolotov SL, Semenov VA (1997) Study of bromantan metabolites structure. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (5). Sport & Buch Strauss, Cologne, Germany, pp 287-300
45. Smith DJ (1998) The pharmacokinetics, metabolism, and tissue residues of β-adrenergic agonists in livestock. J Anim Sci 76:173-194
46. Soni MG, Crabin IG, Griffiths JC, Burdock GA (2004) Safety of ephedra: lessons learned. Toxicol Lett 150:97-110
47. Spyridaki MH, Kiousi P, Vonaparti A, Valavani P, Zonaras V, Zahariou M, Sianos E, Tsoupras G, Georgakopoulos C (2006) Doping control analysis in human urine by liquid chromatography-electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: determination of corticosteroids and quantification of ephedrines, salbutamol and morphine. Anal Chim Acta 573-574:242-249
48. Stahl E (1958) Thin-Layer chromatography. II: standardization, visualization, documentation and, analytical application. Chem Ztg 82:323-329
49. Swain RA, Harsha DM, Baenziger J, Saywell RM (1997) Do pseudoephedrine or phenylpropanol-amine improve maximum oxygen uptake and time to exhaustion? Clin J Sport Med 7:168-173
50. Sweetman SC (ed) (2007) The complete drug reference (Martindale). The Pharmaceutical Press, London
51. Thevis M, Schänzer W (2005) Examples of doping control analysis by liquid-chromatography-tandem mass spectrometry: ephedrines, β-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins. J Chromatogr Sci 43:22-31
52. Thevis M, Schänzer W (2007) Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 388:1351-1358
53. Thevis M, Opfermann G, Schänzer W (2003) Liquid chromatography/ electrospray ionization tandem mass spectrometric screening and confirmation methods for β-agonists in human or equine urine. J Mass Spectrom 38:1197-1206
54. Trout G, Kazlauskas R (2004) Sports drug testing-an analyst's perspective. Chem Soc Rev 33:1-13
55. Tseng YL, Uralets V, Lin CT, Kuo FH (2005) Detection of modafinil in human urine by gas chromatography-mass spectrometry. J Pharm Biomed Anal 39:1042-1045
56. Tswett M (1906) Physical studies on chlorophyll adsorptions. Ber Dtsch Chem Ges 24:316
57. Turner M, Mc Crory P, Johnston A (2005) Time for tea, anyone? Br J Sports Med 39e:37-38
58. Ueki M, Ikekita A, Okano M, Hiruma T (1997) Bromantane - Japanese experience. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (5). Sport & Buch Strauss, Cologne, Germany, pp 279-286
59. Van de Kerkhof D, de Boer D, Maes RAA (1998) The position of the hydroxygroup in the main bromantane metabolite. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis. Sport & Buch Strauss, Cologne, Germany, pp 111-116
60. Van Eenoo P, Delbeke FT (2004) Criteria in chromatography and mass spectrometry-a comparison between regulations in the field of residue and doping analysis. Chromatographia 59: S39-S44
61. Van Eenoo P, Delbeke FT, Roels K, De Backer P (2001) Simultaneous quantitation of ephedrines in urine by gas chromatography-nitrogen-phosphorus detection for doping control purposes. J Chromatogr B 760:255-261
62. Van Eenoo P, Deventer K, Delbeke FT (2006) Quantitative LC-MS determination of strychnine in urine after ingestion of a Strychnos nux-vomica preparation and its consequences in doping control. Forensic Sci Int 164:159-163
63. Van Thuyne W, Delbeke FT (2006) Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list. Int J Sports Med 27:745-750
64. Van Thuyne W, Roels K, Delbeke FT (2005) Distribution of caffeine levels in urine in different sports in relation to doping control. Int J Sports Med 26:714-718
65. Van Thuyne W, Van Eenoo P, Delbeke FT (2006) Nutritional supplements: prevalence of use and contamination with doping agents. Nutr Res Rev 19:147-158
66. Van Thuyne W, Van Eenoo P, Delbeke FT (2007) Comprehensive screening method for the qualitative detection of narcotics and stimulants using single step derivatisation. J Chromatogr B 857:259-265
67. Van Thuyne W, Van Eenoo P, Delbeke FT (2008) Implementation of gas chromatography combined with simultaneous selected ion monitoring and full scan mass spectrometry in doping analysis. J Chromatog A 1210:193-202
68. Van Wimersma Greidanus TB (2000) Stmulantia. In: Hartgens F, Kuipers H (eds) Verboden middelen in de sport. Bohn Stafleu Van Loghum, Houtem, The Netherlands
69. Ventura R, Damasceno L, Farré M, Cardoso J, Segura J (2000) Analytical methodology for the detection of β2-agonists in urine by gas-chromatography for application in doping control. Anal Chim Acta 418:79-92
70. WADA, The World Anti-Doping Agency (2008a). The Laboratory statistics. http://www.wada-ama.org/
71. WADA, The World Anti-Doping Agency (2008b). The World Anti Doping Code, The 2008 Prohibited List, International Standard http://www.wada-ama.org/
72. Yonamine M, Garcia PR, de Moraes Moreau RL (2004) Non-intentional doping in sports. Sports Med 34:697-704